Openhelix
Openhelix provides an AI copilot designed to enhance commercial excellence for life science sales and operations teams. This platform automates administrative tasks like TOV reporting and integrates CRM, claims, and lab data into actionable intelligence for sales representatives. The system aims to increase field time, improve coaching effectiveness, and drive better commercial outcomes by making every rep perform at a higher level.
- Data & Analytics
- Healthcare Technology
- Software Only
Funding
Raised to date
$0Raised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
across 1 round
Founders
Product
Problem
Healthcare companies often struggle to gather timely, relevant market insights from specialist physicians due to their limited accessibility and the difficulty of engaging them for market research. Traditional methods of gathering physician feedback are often slow, expensive, and lack the depth required for informed decision-making.
Solution
Openhelix provides a platform that connects healthcare companies with elite specialist physicians, enabling access to proprietary healthcare intelligence through custom surveys and expert consultations. The platform facilitates the creation and distribution of custom surveys to targeted specialists, with results delivered within five weeks. Openhelix also offers direct video conferences with specialists for in-depth market insights and expert consultations. The platform provides ratings across six key metrics from high-prescribing physicians, covering the top 150 drugs with physician commentary.
Target Audience
The primary target audience includes healthcare companies, pharmaceutical firms, and medical device manufacturers seeking timely and relevant market insights from specialist physicians.
Features
- Custom surveys with results delivered within 5 weeks
- Direct video conferences with distinguished specialists for in-depth market insights
- Drug ratings across 6 key metrics from high-prescribing physicians, covering the top 150 drugs with physician commentary
- Access to a network of leading medical experts, including key opinion leaders in various specialties
- Case studies demonstrating successful applications of the platform for market evaluation, launch strategy optimization, and treatment evolution analysis